Jazz Pharmaceuticals plcEquity-NMS: JAZZ
Equity-NMS: JAZZ
$105.51
-1.45
(22 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$105.51
Open
$105.51
Today’s high
$108.21
Today’s low
$105.41
52W low
$103.01
52W high
$146.7
1Y
-20.58%
5Y
-5.62%
PE
20.39
EPS (TTM)
4.78
Shares O/S
63.04M
Market cap
6.65B
Insights
JAZZ has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
JAZZ price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection.

The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD). .


FAQs

Can I buy Jazz Pharmaceuticals plc shares in India?
How to buy Jazz Pharmaceuticals plc shares in India?
What is the share price of Jazz Pharmaceuticals plc?
What is the Market Capitalization of Jazz Pharmaceuticals plc?
What is the PE ratio of Jazz Pharmaceuticals plc?
Is Jazz Pharmaceuticals plc a good stock to buy?
In which sector / industry does Jazz Pharmaceuticals plc operate?